CTRI/2011/10/002079已完成4 期
Comparison of efficacy and safety of Ciprofloxacin and Cefpodoxime in acute exacerbation of chronic suppurative otitis media: a randomized open labeled study
Arijit Ghosh0 个研究点目标入组 42 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Adults of either sex
- •2.Aged between 18 and 60
- •3.Clinically documented cases of tubo-tympanic type chronic suppurative otitis media defined as long standing chronic suppuration of middle ear cleft and its muco-periosteal lining resulting in discharging ear and deafness presenting with clinical symptoms and signs of acute exacerbation of the disease
- •4.Baseline otological symptom score of more than 4 but less than 8
排除标准
- •1.Female patients who are pregnant or lactating 2.Severe cases of AECSOM for which hospitalization or parenteral antibiotic treatment is required and
- •3. Patients with otological symptom score of less than4 and more than 8 will be also excluded from the study.
- •4.Patients with foul smelling discharge and those who received antibiotic in preceding 4 weeks of screening will be left out.
研究者
相似试验
已完成
3 期
The effects of ciprofloxacin on the treatment of bacterial otitis mediaIRCT20130427013136N7Babol University of Medical Sciences80
已完成
3 期
Comparison of the therapeutic effect of ciprofloxacin and Combination of ciprofloxacin and propolis on women with cystitisIRCT20180721040552N1Ghoum University of Medical Sciences120
已完成
2 期
Efficacy of Oral Ciprofloxacin in acute endophthalmitis prophylaxisIRCT2014060818004N1Vice chancellor for research , Zahedan University of Medical Sciences60
尚未招募
Unknown
Comparative in vivo evaluation of 2 Ciprofloxacine 500 mg Tablet formulations.IRCT20180620040164N62Cosar Pharmaceutical Co.24
已完成
不适用
Comparative in vivo evaluation of 2 Ciprofloxacine 500 mg mg Tablet formulations.IRCT20180620040164N31Dorsa Pharmaceutical Co.24
